BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19853614)

  • 1. The 19S ATPase S6a (S6'/TBP1) regulates the transcription initiation of class II transactivator.
    Truax AD; Koues OI; Mentel MK; Greer SF
    J Mol Biol; 2010 Jan; 395(2):254-69. PubMed ID: 19853614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 19S proteasome ATPase Sug1 plays a critical role in regulating MHC class II transcription.
    Bhat KP; Turner JD; Myers SE; Cape AD; Ting JP; Greer SF
    Mol Immunol; 2008 Apr; 45(8):2214-24. PubMed ID: 18215421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 19S proteasome positively regulates histone methylation at cytokine inducible genes.
    Koues OI; Dudley RK; Mehta NT; Greer SF
    Biochim Biophys Acta; 2009; 1789(11-12):691-701. PubMed ID: 19660582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression.
    Bhat KP; Truax AD; Brooks JK; Greer SF
    Immunol Cell Biol; 2010; 88(8):807-16. PubMed ID: 20351748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter.
    Beresford GW; Boss JM
    Nat Immunol; 2001 Jul; 2(7):652-7. PubMed ID: 11429551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
    Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
    Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
    Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    Dong Y; Rohn WM; Benveniste EN
    J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
    Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators.
    Lee D; Ezhkova E; Li B; Pattenden SG; Tansey WP; Workman JL
    Cell; 2005 Nov; 123(3):423-36. PubMed ID: 16269334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.
    Piskurich JF; Wang Y; Linhoff MW; White LC; Ting JP
    J Immunol; 1998 Jan; 160(1):233-40. PubMed ID: 9551976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
    Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
    J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonproteolytic roles of 19S ATPases in transcription of CIITApIV genes.
    Maganti N; Moody TD; Truax AD; Thakkar M; Spring AM; Germann MW; Greer SF
    PLoS One; 2014; 9(3):e91200. PubMed ID: 24625964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of acetylation at the major histocompatibility complex class II proximal promoter by the 19S proteasomal ATPase Sug1.
    Koues OI; Dudley RK; Truax AD; Gerhardt D; Bhat KP; McNeal S; Greer SF
    Mol Cell Biol; 2008 Oct; 28(19):5837-50. PubMed ID: 18662994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.
    Xi H; Goodwin B; Shepherd AT; Blanck G
    Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO.
    Inostroza-Nieves Y; Venkatraman P; Zavala-Ruiz Z
    Immunol Lett; 2012 Sep; 147(1-2):67-74. PubMed ID: 22771340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.